煌めく神経治療学の明日を目指して

抄録

The Japanese Society of Neurological Therapeutics has promoted (1) publication of treatment guidelines for rare diseases, (2) industry–government–academia collaboration, (3) globalization, and (4) support of clinical trials. In the future its role will be expanded focusing on clinical trial support and drug recovery/development. In 2021, the committee for promotion of drug discovery has been launched. The committee will activate (1) research and development, advices on the trial protocol and participating institutes, (2) support for collection of participants (patients), matching of industry and academia, (3) development of trial–ready registry, and (4) patient and public involvement. Separately, the idea for novel treatments is more likely to be arising from young neurologists. The Japanese Society of Neurological Therapeutics should play an important role in the promotion of drug recovery and clinical trials.